Search database
Filter
3685
Featured
Language
Document type
2142
529
408
161
122
92
79
51
37
32
17
8
6
1
Countries
262
148
145
127
112
93
91
85
80
73
70
59
59
56
55
50
47
47
44
44
44
41
39
37
34
28
27
26
26
24
24
23
21
20
19
18
18
17
14
14
14
13
13
13
11
11
11
11
10
10
10
9
9
9
9
9
8
8
7
7
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
499
237
126
115
88
87
68
67
62
26
24
23
23
21
21
20
19
19
19
18
17
17
17
16
16
16
15
14
13
13
13
12
12
12
12
11
11
11
11
11
11
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1523
439
169
152
95
84
29
Toolboxes
419
361
278
182
162
121
113
103
93
91
61
61
59
43
43
39
37
36
22
21
19
12
2
 Download
  View PDF
 Add to my MEDBOX

Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika
recommended

World Health Organisation (WHO) (2023) C_WHO
A person who lives in or has traveled in the previous 14 days to areas with dengue transmission, and presents with acute fever that has typically lasted 2 to 7 days, and two or more of the following clinical manifestations: nausea or vomiting, exant ... more
 External Link
 Add to my MEDBOX

Wired Ebola Educational Course

WiRed International (2014)
Online Training Course Ebola hemorrhagic fever is one of many viral hemorrhagic fevers. It is a severe, often fatal disease in humans and nonhuman primates, and is one of the world's most contagious diseases. However, the infection can be controll ... more
 Download
  View PDF
 Add to my MEDBOX

Zika virus disease epidemic: Preparedness planning guide for diseases transmitted by Aedes aegypti and Aedes albopictus

European Centre for Disease Prevention and Control (2016) C1
The threat posed by Zika virus infection highlights the need to reinforce preparedness arrangements for mosquito-borne diseases in EU/EEA countries, especially for pathogens transmitted by Aedes aegypti and Aedes albopictus. The aim of this document is to highlight measures that can effectively red ... more
 External Link
 Add to my MEDBOX

Chikungunya virus: A general overview

Galán-Huerta K.A., Rivas-Estilla A.M., Fernández-Salas I. et al (2015) C2
Chikungunya virus (CHIKV) is a re-emerging mosquito borne alphavirus responsible for the recent outbreak in the Americas. Immunologically naïve population in the Americas favors the spread of epidemics. Chikungunya fever is characterized by an abr ... more
 External Link
 Add to my MEDBOX

Dengue Clinical Case Management course (DCCM) | Dengue | CDC

Centers for Disease Control and Prevention CDC (2023) C2
Websites last accessed on 31.03.2023 Dengue, Dengue virus, dengue hemorrhagic fever, dengue fever, flavivirus, Aedes mosquitoes, DHF, DF, DSS
 Add to my MEDBOX

Interim Guidance for Humanitarian Workers

Centers of Disease Control CDC (2013)
Travelers planning to conduct humanitarian work in areas where outbreaks of Ebola hemorrhagic fever and Marburg hemorrhagic fever are known to occur need to be familiar with how Ebola virus and Marb ... more
 External Link
 Add to my MEDBOX

Ebola Prevention and Control

A. Dramowski; S. Mehtar Infection Control Africa Network ICAN; Bettercare (2015) C1
Learn together. Managing transmission of viral haemmoraghic fever. Only available online! This book is part of the Bettercare series which addresses the need for continuing education for health professionals. The book is produced under the auspice ... more
 Add to my MEDBOX

Recommendations for management of common childhood conditions
recommended

World Health Organization (2012)
Evidence for technical update of pocket book recommendations. Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care
 Download
  View PDF
 Add to my MEDBOX

Optimized Supportive Care for Ebola Virus Disease
recommended

World Health Organization WHO (2019) C_WHO
Clinical management standard operating procedures. Ebola virus disease (EVD) is a life-threatening multisystem illness associated with fever and gastrointestinal (GI) symptoms that frequently leads to hypovolaemia, metabolic acidosis, hypoglycaemia ... more
 Download
  View PDF
 Add to my MEDBOX

WHO AFRO Outbreaks and Other Emergencies, Week 27: 1 - 7 July 2019; Data as reported by 17:00; 7 July 2019

World Health Organization WHO (2019) C_WHO
Circulating vaccine-derived poliovirus type 2 in Angola Ebola virus disease in Democratic Republic of the Congo Dengue fever in Côte d’Ivoire Humanitarian crisis in north-east Nigeria.
 External Link
 Add to my MEDBOX

Factsheet for health professionals about Marburg virus disease

European Centre for Disease Prevention and Control (ecdc) (2024) C_CDC
Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe disease in humans caused by Marburg marburgvirus (MARV). Although MVD is uncommon, MARV has the potential to cause epidemics with significant case fatality rates. ... more
 Download
  View PDF
 Add to my MEDBOX

Guidance on temporary malaria control measures in Ebola-affected countries

World Health Organization (2014)
Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leone can be optimized through the deployment of targe ... more
 Download
  View PDF
 Add to my MEDBOX

Vector control operations framework for Zika virus

World Health Organization WHO (2016) C_WHO
Zika virus is primarily transmitted by the Aedes species of mosquito which is also responsible for the spread of dengue, Chikungunya and yellow fever viruses. In most areas, the primary vector of these viruses is Aedes aegypti, with Aedes albopictus ... more
 Download
  View PDF
 Add to my MEDBOX

Communicable Disease Threats Report, 7-13 August 2016, Week 32

European Centre for Disease Prevention and Control (2016)
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiolgists and health professionals on active public health threats. This issue covers the period 7-13 August 2016 and includes updates on Zika virus, yellow fever in ... more
 Download
  View PDF
 Add to my MEDBOX

Communication Risk in Public Health Emergencies
recommended

World Health Organization (WHO) (2018) C_WHO
A WHO Guideline for Emergency Risk Communication (ERC) policy and practice. Recent public health emergencies, such as the Ebola virus disease outbreak in West Africa (2014–2015), the emergence of the Zika virus syndrome in 2015–2016 and multi-country yellow ... more
 Download
  View PDF
 Add to my MEDBOX

Public information on biological and chemical threats (English/Arabic)

World Health Organization (WHO) (2003) C_WHO
The purpose of this document is to inform the public about biological and chemical hazards and thereby prepare the population for an immediate response in the event of an incident until public health support is provided. The agents reported here are: Anthrax, Botulism, Haemorrhagic ... more
 Download
  View PDF
 Add to my MEDBOX

A toolkit for integrated vector management in sub-Saharan Africa

World Health Organization (WHO) (2016) C_WHO
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can ... more
 Download
  View PDF
 Add to my MEDBOX

WHO AFRO Outbreaks and Other Emergencies, Week 13: 25 - 31 March 2019; Data as reported by 17:00; 31 March 2019

World Health Organization WHO (2019) C_WHO
Response to the tropical cyclone in southern Africa Ebola virus disease outbreak in the Democratic Republic of the Congo Meningitis outbreak in Togo Lassa fever outbreak in Liberia.
 Add to my MEDBOX

Does the patient meet the case definition for a COVID-19 case?

Nation Institute for Communicable Diseases - Division of the National Health Laboratory Service Department: Health Republic of South Africa (2020) C2
Persons with acute respiratory illness with sudden onset of at least one of the following: cough, sore throat, shortness of breath or fever [≥ 38°C (measured) or history of fever (subjective)] ir ... more
 External Link
 Add to my MEDBOX

Q&A: Antibiotic resistance: where does it come from and what can we do about it?

Wright G.D. BMC Biology (2010) C2
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre- ... more
 External Link
 Add to my MEDBOX

Coronavirus (COVID-19) (Arabic)

NHS Inform Scottland (2021) CC
Coronavirus (COVID-19) is the illness caused by a new strain of coronavirus first identified in Wuhan city, China. It can cause a cough and/or a fever/high temperature. These are Arabic versions of the latest coronavirus (COVID-19) guidance.
 Download
  View PDF
 Add to my MEDBOX

Understanding How COVID-19 Vaccines Work

Centers for Disease Control and Prevention CDC (2021) C_CDC
27 May 2021 COVID-19 vaccines teach our immune systems how to recognize and fight the virus that causes COVID-19. Sometimes this process can cause symptoms, such as fever. These symptoms are normal and are signs that the body is building protectio ... more
 Download
  View PDF
 Add to my MEDBOX

A Tripartite Zoonosis Guide (TZG)

Food and Agriculture Organization of the United Nations FAO; World Health Organization (WHO), et al. (2019) C_WHO
Taking a multisectoral, One Health approach is necessary to address complex health threats at the human-animal-environment interface, such as rabies, zoonotic influenza, anthrax, and Rift Valley fever. Such zoonotic diseases continue to have major i ... more
 External Link
 Add to my MEDBOX

Monkeypox: Introductory course for African outbreak contexts

World Health Organization (WHO) (2020) C_WHO
Monkeypox virus is an orthopoxvirus that causes human monkeypox, a viral disease with symptoms similar to smallpox, including fever and rash. Following the worldwide eradication of smallpox in 1980, monkeypox emerged as the most significant orthopox ... more
 External Link
 Add to my MEDBOX

Clinical Course and Outcome of Human Monkeypox in Nigeria

Ogoina, D.; Iroezindu, M.; Izibewule, J.H. et al. (2020) CC
In a retrospective review of hospital records of 40 human monkeypox cases from Nigeria, the majority developed fever and self-limiting vesiculopustular skin eruptions. Five deaths were reported. Compared to human immunodeficiency virus (HIV)–nega ... more
 External Link
 Add to my MEDBOX

Pakistan: Dengue Outbreak - Sep 2022

Office for the Coordination of Humanitarian Affairs OCHA (2022) C1
the current surge in cases follows unprecedented flooding that began in mid-June 2022. With the current flood crisis affecting the national health system capacity and the growing humanitarian situation, there is a high risk of serious health impacts from dengue ... more
 External Link
 Add to my MEDBOX

Parasites - Guinea Worm

Center for Disease Control and Prevention CDC (2003) CC
People with Guinea worm disease (GWD) have no symptoms for about 1 year. Then, the person begins to feel ill. Symptoms can include the following: Slight fever Itchy rash Nausea Vomiting Diarrhea Dizziness A blister then develops. This blist ... more
 External Link
 Add to my MEDBOX

Visceral leishmaniasis

Drugs for Neglected Diseases initiative DNDi (2023) CC
Visceral leishmaniasis, the most severe form of leishmaniasis also known as kala-azar, is a life-threatening disease caused by Leishmania parasites which are transmitted by female sandflies. Visceral leishmaniasis causes fever, weight loss, spleen a ... more
 Add to my MEDBOX

Mpox Outbreak Toolbox, Updated: January 2023

World Health Organization WHO; Health Cluster (2024) CC
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pai ... more
 Add to my MEDBOX

Health emergency preparedness for imported cases of high-consequence infectious diseases

European Centre for Disease Prevention and Control (ecdc) (2022) C_CDC
Preparedness planning is essential in order to respond effectively to outbreaks, including single case occurrences of highconsequence infectious diseases (HCID), such as the importation of a viral haemorrhagic fever (VHF) case
 External Link
 Add to my MEDBOX

Lessons Learnt from the Marburg Virus Disease (MVD) Outbreak in Tanzania

Africa CDC (2023) C_CDC
On March 16, 2023, the Tanzania Ministry of Health declared an outbreak of an unidentified illness in Bukoba district, Kagera region. A group of seven individuals presented with fever, vomiting, bleeding from various body orifices, and kidney failur ... more
 Add to my MEDBOX

Provider-initiated HIV testing and TB screening in the era of universal coverage: Are the right people being reached? A cohort study in Blantyre, Malawi

Mair, L.; Corbett, E. L.; Feasey, H. R. A.; et al. PLOS One (2020) CC2
In a prospective cohort study in Bangwe primary care clinic, Blantyre, Malawi, all adults (18 years or older) presenting with an acute illness were screened for TB symptoms (cough, fever, night sweats, weight loss). Demographic characteristics were ... more
 Download
  View PDF
 Add to my MEDBOX

Building capacity for creating demand in support of malaria prevention and control

Sue George, John Dada, Kolawole Maxwell et al. Malaria Consortium (2014)
In the context of the Support to National Malaria Control Programme (SuNMaP), demand creation is the strategic combination of advocacy, communication and mobilisation approaches that seek to achieve increased community awareness of, and demand for, effective malaria prevention and treatment services ... more
 Download
  View PDF
 Add to my MEDBOX

Manual for the care and management of patients in Ebola Care Units/ Community Care Centres - Interim emergency guidance, January 2015
recommended

World Health Organization (2015)
This manual provides guidance on best practices to be followed in Ebola Care Units (ECUs)/Community Care Centres (CCCs). It is intended for health aid workers (including junior nurses and community health-care workers) and others providing care for patients in ECUs/CCCs. While the focus is on the ca ... more
 External Link
 Add to my MEDBOX

Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis
recommended

Patrick G T Walker, Michael T White, Jamie T Griffin, et al. (2015)
The ongoing Ebola epidemic in parts of West Africa largely overwhelmed health-care systems in 2014, making adequate care for malaria impossible and threatening the gains in malaria control achieved over the past decade. The study suggests that untreated malaria cases as a result of reduced health-ca ... more
 Add to my MEDBOX

Prevansyon kont diare

Organización Panamericana de la Salud (2016) C2
The document "Prevansyon kont Diare" provides guidance on preventing and managing diarrhea. It explains that diarrhea, caused by pathogens like viruses, bacteria, and parasites, can lead to severe dehydration if untreated. Symptoms include vomiting, fever ... more
 Download
  View PDF
 Add to my MEDBOX

Boîte à outils pour une gestion vectorielle intégrée en Afrique subsaharienne

Organisation mondiale de la Santé (OMS) (2016) C_WHO
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes. The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can be ... more
 Download
  View PDF
 Add to my MEDBOX

Gaps in service Utilization and service provision: an analysis of DHS and SPA Malaria data from Malawi, Senegal, and Tanzania

C. Taylor, A. Linn, W. Wang, and H. Moussa (2018) C2
Barriers to the prompt and effective diagnosis and treatment of malaria exist at both the community and health facility level. Household surveys measure malaria case management at the population level with standard indicators that assess treatment-seeking behavior, access to diagnostic testing, and ... more
 Add to my MEDBOX

Maldives National Action Plan for Containment of Antimicrobial Resistance 2017-2022

Maldives Food and Drug Authority Ministry of Health (2017) C2
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati ... more
 External Link
 Add to my MEDBOX

Disease Commodity Packages

World Health Organization WHO (2020) C_WHO
The DCPs are a series of disease specific datasheets that list the critical commodities and the technical specifications for each commodity per disease. The DCPs inform Member States and operational partners of commodity requirements and potential gaps in the health emergency supply chain. From an o ... more
 Download
  View PDF
 Add to my MEDBOX

Coronavirus Disease 2019 (COVID-19) Discharge Instructions

Wolters Kluwer; Clinical Drug Information, Inc. and its affiliates andor licensors (2020) C2
Coronavirus disease 2019 is also known as COVID-19. It is a viral illness that infects the lungs. It is caused by a virus called SARS-associated coronavirus (SARS-CoV-2). This illness was first seen in late 2019 in China and has spread across the world. The signs of COVID-19 are like the flu, and y ... more
 Add to my MEDBOX

WHO Immunological Basis for Immunization Series: Module 14: cholera

World Health Organization WHO (2010) C_WHO
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i ... more
 Add to my MEDBOX

National Monkeypox Public Health Response Guidelines

Federal Ministry of Health - Nigeria Centre for Disease Control (2019) CC
Since the re-emergence of monkeypox in Nigeria in September 2017, the Nigeria Centre for Disease Control(NCDC) has continued to receive reports and respond to cases of the disease from States across the country. Between September 2017 when the outbreak started and November 2018, about 300 suspecte ... more
 External Link
 Add to my MEDBOX

Schistosomiasis: Still a Cause of Significant Morbidity and Mortality

Verjeen, M. National Library of Medicine (2019) CC
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm ... more
 Add to my MEDBOX

Dengue epidemiology

Jing, Q.; Wang, M. Global Health Journal (2019) CC
Dengue is the fastest spreading, mosquito-borne viral infectious disease worldwide, with remarkable morbidity and mortality. In the past decades, profound contributions have been made towards understanding its epidemiology, including disease burden and distributions, risk factors, and control and pr ... more
 External Link
 Add to my MEDBOX

Leptospirosis in sugarcane plantation and fishing communities in Kagera northwestern Tanzania

Mgode, G.; Japhary, M.; Mhamphi, G. et al. PLoS Neglected Tropical diseases (2019) CC
Leptospirosis is a bacterial zoonotic disease of worldwide importance, though relatively neglected in many African countries including sub Saharan Africa that is among areas with high burden of this disease. The disease is often mistaken for other febrile illnesses such as dengue, malaria, rickettsi ... more
 Download
  View PDF
 Add to my MEDBOX

Acute schistosomiasis, a diagnostic and therapeutic challenge

Jauréguiberry S., Paris L., Caumes E. (2010) C2
Clin Microbiol Infect 2010; 16: 225–231 Abstract In non-endemic countries, acute (invasive) schistosomiasis (AS) is typically seen in non-immune travellers, whereas chronic schistosomiasis is more frequently diagnosed in immigrants. Travellers with AS initially present with non-specific signs such ... more
 Add to my MEDBOX

Communicable and non-communicable diseases in Africa in 2021/22

World Health Organization Africa Region; WHO Africa World Health Organization Africa Region; WHO Africa (2023) C_WHO
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra ... more
 Add to my MEDBOX

Strategic Framework for Enhancing Prevention and Control of mpox, 2024-2027

World Health Organization WHO (2024) C_WHO
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani ... more
 Add to my MEDBOX

Silicosis - occupational lung disease

Mediclinic Southern Africa Mediclinic Southern Africa (2024) CC2
The Mediclinic article on silicosis provides an overview of this occupational lung disease caused by inhaling silica dust. It explains that inhaled silica particles lead to lung scarring and nodule formation, progressively impairing breathing. The article outlines symptoms such as shortness of breat ... more
 Add to my MEDBOX

Silicosis - Silicosis is an occupational lung disease caused by inhaling silica dust

Mediclinic Southern Africa Mediclinic Southern Africa (2024) CC2
The Mediclinic Infohub article on silicosis provides an overview of this occupational lung disease caused by inhaling silica dust. It explains that inhaled silica particles lead to lung scarring and nodule formation, progressively impairing breathing. The article outlines symptoms such as shortness ... more
 Add to my MEDBOX

What is Asthma?

National Asthma Education Programme (2012) CC2
Asthma: • is one of the most common respiratory complaints in the world today. • affects one in ten children (10%) and one in twenty adults (5%) • can occur for the first time at any age, even in adulthood. •usually begins before the age of five years. A few children affected will ... more
 Add to my MEDBOX

Ganemos tiempo podria ser tuberculosis - Video

Nuevo Hospital Quellón Youtube (2024) C2
The video titled "Ganemos tiempo: podría ser tuberculosis" (Let's save time: it could be tuberculosis) is part of a public health campaign aimed at raising awareness about tuberculosis (TB). It emphasizes the importance of early detection and timely treatment to combat the disease effectively. The ... more
 Download
  View PDF
 Add to my MEDBOX

More time or more money to improve nutrition in Benin Republic?

M. C. D. N. Vodouhe, L. Fakambi Institut National des Recherches Agricoles du Bénin (INRAB) (2015) C2
Children malnutrition eradication in developing countries is a real challenge, especially among vulnerable population. There are so many effort towards women (who are the main care providers) socio-economic situation in order to improve their children nutrition. This article aims to identify the ... more
 Download
  View PDF
 Add to my MEDBOX

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... more
 External Link
 Add to my MEDBOX

Dengue Clinical Case Management course (DCCM)

Centers for Disease Control and Prevention CDC (2020) C_CDC
PROGRAM DESCRIPTION: Course is designed to increase knowledge and develop competency in the management of patients suspected of infection with dengue virus.
 External Link
 Add to my MEDBOX

Self-learning course: Clinical diagnosis and management of dengue

Pan American Health Organization PAHO ; World Health Organization WHO (2021) C_WHO
This first online course is geared at helping healthcare workers in diagnosing and managing all aspects of dengue in order to avoid complications and fatalities. This course was developed with a comprehensive vision. It is divided into seven modules that include: Epidemiological informatio ... more
 External Link
 Add to my MEDBOX

Curso de autoaprendizaje: Diagnóstico y manejo clínico del dengue

Pan American Health Organization PAHO ; World Health Organization WHO (2020) C_WHO
El propósito de este curso es proveer al personal de salud encargado de atender casos sospechosos de dengue la información necesaria para realizar un diagnóstico y manejo clínico oportuno, evitando la progresión a las formas graves y las muertes ocasionadas por esta enfermedad.
 Add to my MEDBOX

Report on the epidemiological situation of dengue in the Americas, June 2024

Pan American Health Organization PAHO (2024) C_WHO
Between epidemiological weeks (EW) 1 and 22 of 2024, a total of 9,541,015 suspected cases of dengue were reported, resulting in a cumulative incidence of 1,011 per 100,000 population. This represents an increase of 230% compared to the same period in 2023 and 421% compared to the average of the last ... more
 Download
  View PDF
 Add to my MEDBOX

How to conduct safe and dignified burial of a patient who has died from suspected or confirmed Ebola or Marburg virus disease

World Health Organization WHO (2014) C_WHO
This protocol provides information on the safe management of dead bodies and burial of patients who died from suspected or confirmed Ebola or Marburg virus disease. These measures should be applied not only by medical personnel but by anyone involved in the management of dead bodies and burial of su ... more
 Add to my MEDBOX

Revised National Guidelines on Mpox

Wasif Malik, M.; et al. National Institute of Health, Pakistan (2024) CC
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
 Add to my MEDBOX

Case definitions, clinical classification, and disease phases

Pan American Health Organization PAHO (2023) C_WHO
The purpose of this document is to present concise information on the current case definitions for dengue, chikungunya, and Zika proposed by PAHO, as well as information on the clinical phases and severity classification of dengue and chikungunya.
 External Link
 Add to my MEDBOX

Marburg virus disease

World Health Organisation (WHO) (2024) C_WHO
Fact Sheet
 External Link
 Add to my MEDBOX

Marburg Virus Updates 27.10.2024

Ministry of Health Rwanda; Rwanda Biomedical Centre (2024) CC
Please find here the latest Update on MVD in Rwanda
 Add to my MEDBOX

Ebola and Marburg disease outbreaks: infection prevention and control research priorities in health care settings

World Health Organisation (WHO) (2024) C_WHO
Ebola virus (EBOV) and Marburg virus (MARV) are associated with severe, potentially fatal, systemic diseases. During the development of the Infection Prevention and Control Guideline for Ebola Disease and Marburg Disease, the Guideline Development Group (GDG) identified multiple research gaps in key ... more
 Download
  View PDF
 Add to my MEDBOX

Contrôle de l´infection en cas de fièvre hémorragique virale en milieu hospitalier africain

Organisation Mondiale de la Santé OMS; CDC (1998)
 Add to my MEDBOX

Fièvres Hémorragiques Virales

Pierre Aubry (2014)
 Add to my MEDBOX

Port de vêtements protecteurs

Organisation Mondiale de la Santé OMS (1998)
 Add to my MEDBOX

Élimination sans risques des déchets

Organisation Mondiale de la Santé OMS (1998)
 Download
  View PDF
 Add to my MEDBOX

Controlo do Contágio sobre Febres Hemorrágicas Virais no contexto dos ser viços Africanos de Saúde

World Health Organization; Centers of Disease Controle CDC (2004)
 Download
  View PDF
 Add to my MEDBOX

Management and Control of Viral Haemorrhagic Fevers and other highly contagious viral pathogens

European Network for Diagnostics of Imported Viral Diseases (2001) C1
 Download
  View PDF
 Add to my MEDBOX

Guide OMS pour la préparation et la riposte aux épidémies: Fièvre hémorragique à virus Ebola

World Health Organization (1997)
 Download
  View PDF
 Add to my MEDBOX

Prise en charge clinique des cas de fièvre hémorragique virale
recommended

World Health Organization, Regional Office for Africa; (2016) C_WHO
Guide de poche pour l’agent de santé en première ligne Ce guide s’intéresse plus particulièrement à certaines fièvres hémorragiques virales (FHV) Ebola, Marburg, FHCC, fièvre de Lassa [et Lujo] – qui surviennent en Afrique et risquent de donner lieu à une transmission interhumaine. I ... more
 Download
  View PDF
 Add to my MEDBOX

Fièvre Hémorragique à Virus Ebola (FHVE). Aide-mémoire du mobilisateur

Ministry of Health, Democratic Republic of Congo (2014)
Accessed 1 July 2014
 Download
  View PDF
 Add to my MEDBOX

Ebola Outbreak Preparedness & Management

Baert, B. MSF (2001) C1
 Download
  View PDF
 Add to my MEDBOX

Ebola and Marburg virus disease epidemics: preparedness, alert, control, and evaluation
recommended

World Health Organization (2014) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Flambées épidémiques de maladie à virus Ebola et Marburg: préparation, alerte, lutte et évaluation
recommended

Organisation Mondiale de la Santé OMS (2014) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Prévention et contrôle de l’infection pour les soins aux cas suspects ou confirmés de fièvre hémorragique à filovirus dans les établissements de santé, avec un accent particulier sur le virus Ebola
recommended

Organisation Mondiale de la Santé OMS (2014)
Guide provisoire
 Download
  View PDF
 Add to my MEDBOX

Potential Ebola Therapies and Vaccines

World Health Organization (2014)
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level. The aim of the document is to assist Member States and releva ... more
 Download
  View PDF
 Add to my MEDBOX

Normes de surveillance Fièvre jaune

Organisation de la Santé Mondiale (2000) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Clinical care for survivors of Ebola virus disease
recommended

World Health Organization (WHO) (2016) C_WHO
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ... more
 Add to my MEDBOX

Communication et mobilisation sociale dans les campagnes de vaccination contre la fièvre jaune

Organisation Mondiale de la Santé OMS (2015) C_WHO
10 points basés sur l’expérience de terrain
 Add to my MEDBOX

Surveillance des manifestations indésirables consécutives à la vaccination contre la fièvre jaune

Organisation Mondiale de la Santé OMS (2010) C_WHO
GUIDE OPÉRATIONNEL à l'usage du personnel de niveau central, intermédiaire et périphérique
 Download
  View PDF
 Add to my MEDBOX

Manejo Clinico Febre Amarela

Secretaria de Estado de Saúde de Minas Gerais (SES-MG) (2017) C1
 Download
  View PDF
 Add to my MEDBOX

Orientação para profissionais de saúde sobre febre amarela silvestre

Ministério da Saúde Secretaria de Vigilância em Saúde, Brazil (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Orientacoes para a vaincacao contra a Febre Amarela

Ministerio da Saude, Brazil (2017) C1
 Download
  View PDF
 Add to my MEDBOX

Preferred product characteristics for personal protective equipment for the health worker on the frontline responding to viral hemorrhagic fevers in tropical climates
recommended

World Health Organization (2018) C_WHO
The scope of this PPC document is to serve as a guide to address the unmet public health need for a PPE system that protects the HW-F in tropical climate s while caring for patients and providing heavy duty essential health services. The characteristics described in this guidance are targeted fo ... more
 Download
  View PDF
 Add to my MEDBOX

Soins cliniques pour les survivants de la maladie à virus Ebola: Guide provisoire
recommended

Organisation mondiale de la Santé (OMS) (2016) C_WHO
Ce document présente des recommandations sur les soins cliniques et le dépistage du virus chez les survivants de la maladie à virus Ebola. Il s'adresse principalement aux professionnels de santé qui dispensent des soins primaires aux personnes ayant survécu.
Table des matières
... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease
recommended

World Health Organization WHO (2020) C1
To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongo ... more
 Add to my MEDBOX

Manejo clínico da febre amarela na Região das Américas. Experiências e recomendações para os serviços de saúde

Pan American Health Organisation PAHO (2022) C_WHO
 Add to my MEDBOX

Neutralizing monoclonal antibody cocktail REGN-EB3 for Ebola virus disease (EVD)
recommended

World Health Organization WHO (2022) C_WHO
Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
 Add to my MEDBOX

Neutralizing monoclonal antibody mAb114 for Ebola virus disease (‎EVD)‎
recommended

World Health Organization WHO (2022) C_WHO
Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
 Add to my MEDBOX

Anticorps monoclonal neutralisant mAb114 contre la maladie à virus Ebola (‎MVE)‎
recommended

World Health Organization WHO (2022) C_WHO
Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
 Download
  View PDF
 Add to my MEDBOX

Cocktail d’anticorps monoclonaux neutralisant REGN-EB3 contre la maladie à virus Ebola (‎MVE)‎
recommended

World Health Organization WHO (2022) C_WHO
Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
 Add to my MEDBOX

Preparation and administration of REGN-EB3 for Ebola virus disease (‎EVD)‎
recommended

World Health Organization WHO (2022) C_WHO
Guidance for health care workers.
 Download
  View PDF
 Add to my MEDBOX

Préparation et administration de REGN-EB3 contre la maladie à virus Ebola (‎MVE)‎
recommended

World Health Organization WHO (2022) C_WHO
Guidance for health care workers.
 External Link
 Add to my MEDBOX

Manejo clínico de la fiebre amarilla en la Región de las Américas. Experiencias y recomendaciones para los servicios de salud

Pan American Health Organization PAHO (2023) CC
Las olas de transmisión de la fiebre amarilla ocurridas en la Región de las Américas entre el 2016 y el 2018 causaron el mayor número de casos humanos y epizoóticos registrados en varios decenios. La fiebre amarilla es una enfermedad hemorrágica viral grave que representa un desafío para el p ... more
 Download
  View PDF
 Add to my MEDBOX

Infection prevention and control guideline for Ebola and Marburg disease, August 2023
recommended

World Health Organization WHO (2023) CC
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected. Infection prevention and control (IP ... more
 Add to my MEDBOX

Précautions standard pour contrôler les infections à l’'hôpital

Organisation Mondiale de la Santé OMS (1998)
 Download
  View PDF
 Add to my MEDBOX

Fièvre de Lassa : Introduction. Cours

World Health Organization WHO (2018) C_WHO
La fièvre de Lassa est une fièvre hémorragique virale aiguë d'une durée d'une à quatre semaines qui sévit en Afrique occidentale. La fièvre de Lassa, une fièvre hémorragique virale avec des symptômes similaires à ceux de la maladie virale d'Ebola, est endémique dans une grande partie de ... more